CVS Group plc Exercise of Options & TVR (4752Z)
March 14 2017 - 1:29PM
UK Regulatory
TIDMCVSG
RNS Number : 4752Z
CVS Group plc
14 March 2017
14 March 2017
CVS Group plc
("CVS" or the "Company")
Exercise of Options and Total Voting Rights
CVS, one of the UK's leading provider of integrated veterinary
services for small and large animals, announces that 24,859
ordinary shares of 0.2 pence each ("Ordinary Shares") (the "SAYE
Shares") were issued on 6 March 2017 as a result of the exercise of
employee share options, in connection with the Company's December
2013 - December 2016 Save As You Earn Scheme.
The SAYE Shares rank pari passu with all existing Ordinary
Shares. The issue of the SAYE Shares has been satisfied via the
Company's block listing which was announced on 19 December 2016
(the "Block Listing").
The Company also announces that 965 ordinary shares of 0.2 pence
each (the "New Shares") were issued on 14 March 2017 as a result of
the exercise of employee share options by a former employee, in
connection with the Company's December 2014 - December 2017 and
December 2015 - December 2018 Save As You Earn Schemes. Application
has been made for the New Shares, which rank pari passu in all
respects with the Company's existing Ordinary Shares, to be
admitted to trading on AIM which is expected to occur on or around
20 March 2017.
The former employee also exercised 669 employee share options in
relation to the Company's December 2013 - December 2016 Save As You
Earn Scheme. The issue of these SAYE Shares has been satisfied via
the Block Listing and is included in the issue of 24,859 new
Ordinary Shares as described above.
Following issue of the New Shares and the SAYE Shares, the
Company's total issued share capital will consist of 63,877,906
Ordinary Shares with one voting right per share. The Company does
not hold any Ordinary Shares in Treasury. Therefore, following the
issue of the New Shares, the total number of voting rights in the
Company is 63,877,906. This figure may be used by shareholders as
the denominator for the calculations by which they will determine
if they are required to notify their interest in, or a change to
their interest in, the Company under the FCA's Disclosure Guidance
and Transparency Rules.
Contacts:
CVS Group plc Tel: 01379 644
Simon Innes, Chief Executive 288
Nick Perrin, Finance Director
N+1 Singer (Nominated Adviser Tel: 020 7496
& Broker) 3000
Aubrey Powell
Liz Yong
James Hopton
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEGGURPWUPMGMC
(END) Dow Jones Newswires
March 14, 2017 13:29 ET (17:29 GMT)
Cvs (LSE:CVSG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cvs (LSE:CVSG)
Historical Stock Chart
From Apr 2023 to Apr 2024